Urology Innovations Canada

07/14/2026

Not every man with prostate cancer is a candidate for focal therapy.

HIFU and NanoKnife are designed for localized, well-defined cancer that can be mapped and treated precisely. When disease is multifocal, high-volume, difficult to localize, or extends beyond the prostate, surgery or radiation may be the more appropriate option.

Careful patient selection is one of the most important parts of focal treatment.

Read more about who may not be a good candidate for HIFU or NanoKnife (IRE):

https://urologyinnovationscanada.com/who-is-not-a-good-candidate-for-hifu-or-nanoknife-ire/?utm_source=facebook&utm_medium=post&utm_campaign=hifu_ire_eligibility

Not every man with prostate cancer is a candidate for focal therapy. Treatments like HIFU and NanoKnife depend on precise mapping of localized disease. When cancer is multifocal, high-volume, or difficult to define, a more comprehensive approach may be required. Understanding when focal therapy is n...

06/03/2026

There are two approaches to prostate biopsy: transre**al and transperineal.

With a transre**al biopsy, the needle passes through the re**al wall before entering the prostate. With a transperineal biopsy, the needle passes directly through the skin between the sc***um and re**um into the prostate.

At UIC, we perform only transperineal prostate biopsies because this approach has been associated with lower rates of infection and bleeding compared with traditional transre**al biopsy.

For us, prostate cancer care means thinking about precision and quality of life at every step — starting with the biopsy.

06/01/2026

A recent NanoKnife patient who travelled from B.C. to Toronto shared this kind review:

“The service and staff were first class from start to finish. When I first enquired about the surgery online, Dr. Barkin called me on a Sunday afternoon to answer all my queries… All correspondence with Dr. Barkin, Mary, Vanita and Jennifer was prompt, polite and thorough, before, during and after my procedure… Overall, I cannot recommend Dr. Barkin and his team enough.”

Thank you, Mark, for your generous words and for trusting the Urology Innovations Canada team with your care.

05/15/2026

Modern prostate cancer treatment is increasingly focused on achieving effective results with less disruption to quality of life.

Whenever appropriate, minimally invasive focal treatment can help men avoid major surgery, long hospital stays, and extended recovery — while still effectively treating localized prostate cancer.

At UIC, our focus is always precision, safety, and preserving function whenever possible.

04/08/2026

Like many of our patients, Terry travelled from Calgary to UIC in Toronto for his NanoKnife (IRE) treatment of localized prostate cancer.

Five months later, he shared these follow-up results:

• PSA decreased from 15.5 to 1.8
• Follow-up MRI showed that the lesions were gone
• No urinary incontinence
• No erectile dysfunction

For the right candidate, focal treatment can offer meaningful cancer control without compromising the life you want to keep living.

04/02/2026

Dr. Barkin in Malta this week with leading international IRE physicians, exchanging experience and technique insights on NanoKnife for localized prostate cancer.

Ongoing collaboration with experts in focal therapy helps refine treatment planning, improve precision, and continue advancing care for carefully selected men here in Toronto.

It’s always valuable to be part of the global conversations shaping the future of focal treatment.

04/02/2026

Before treatment, comes the most important step: careful patient selection.

At UIC, every case is reviewed first to determine whether focal therapy is truly the right fit.

For localized prostate cancer, the best outcomes start with choosing the right patients — not simply choosing a technology.

03/31/2026

Twenty years ago, on March 12, 2006, we performed North America's first HIFU treatment for prostate cancer.

𝗪𝗵𝗮𝘁 𝗵𝗮𝘀 𝟮𝟬 𝘆𝗲𝗮𝗿𝘀 𝘁𝗮𝘂𝗴𝗵𝘁 𝘂𝘀?

• Not every localized prostate cancer requires radical treatment

• Precision and patient selection matter more than technology alone

• MRI fusion biopsy changed how accurately we diagnose and plan focal treatment

• Quality of life — including urinary and sexual function — must remain central

• For carefully selected patients, focal treatment can offer cancer control while preserving future options

The most common thing we still hear from men after diagnosis:

"I didn’t realize I had other options."

For men with localized prostate cancer, understanding all available treatment pathways is an important first step.